30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can be used as reliable predictors to evaluate the severity and progression of PDD and VPD remains largely unknown. Methods: We performed a cross-sectional study that included 92 patients with PDD, 82 patients with VPD and 80 healthy controls. Serum levels of TFF3, ChE activity and Hcy were measured. Several scales were used to rate the severity of PDD and VPD. Receivers operating characteristic (ROC) curves were applied to map the diagnostic accuracy of PDD and VPD patients compared to healthy subjects. Results: Compared with healthy subjects, the serum levels of TFF3 and ChE activity were lower, while Hcy was higher in the PDD and VPD patients. These findings were especially prominent in male patients. The three biomarkers displayed differences between PDD and VPD sub-groups based on genders and UPDRS (III) scores’ distribution. Interestingly, these increased serum Hcy levels were significantly and inversely correlated with decreased TFF3/ChE activity levels. There were significant correlations between TFF3/ChE activity/Hcy levels and PDD/VPD severities, including motor dysfunction, declining cognition and mood/gastrointestinal symptoms. Additionally, ROC curves for the combination of TFF3, ChE activity and Hcy showed potential diagnostic value in discriminating PDD and VPD patients from healthy controls. Conclusions: Our findings suggest that serum TFF3, ChE activity and Hcy levels may underlie the pathophysiological mechanisms of PDD and VPD. As the race to find biomarkers or predictors for these diseases intensifies, a better understanding of the roles of TFF3, ChE activity and Hcy may yield insights into the pathogenesis of PDD and VPD.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          Predictors of dementia in Parkinson disease: a prospective cohort study.

          We investigated an array of possible markers of early dementia in Parkinson disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia.

            Mild to moderate hyperhomocysteinemia is a risk factor for neurodegenerative diseases. Human studies suggest that homocysteine (Hcy) plays a role in brain damage, cognitive and memory decline. Numerous studies in recent years investigated the role of Hcy as a cause of brain damage. Hcy itself or folate and vitamin B12 deficiency can cause disturbed methylation and/or redox potentials, thus promoting calcium influx, amyloid and tau protein accumulation, apoptosis, and neuronal death. The Hcy effect may also be mediated by activating the N-methyl-D-aspartate receptor subtype. Numerous neurotoxic effects of Hcy can be blocked by folate, glutamate receptor antagonists, or various antioxidants. This review describes the most important mechanisms of Hcy neurotoxicity and pharmacological agents known to reverse Hcy effects.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Parkinsonism: onset, progression, and mortality. 1967.

                Bookmark

                Author and article information

                Journal
                Aging Dis
                Aging Dis
                Aging and Disease
                JKL International LLC
                2152-5250
                February 2018
                1 February 2018
                : 9
                : 1
                : 51-65
                Affiliations
                [1-ad-9-1-51] 1Department of Neurology, and
                [2-ad-9-1-51] 2Department of Emergency, The Third Affiliated Hospital of Sun Yat-Sen University, China.
                [3-ad-9-1-51] 3Department of Neurology, Guangdong 999 Brain Hospital, Guangzhou, China.
                [4-ad-9-1-51] 4Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, China.
                [5-ad-9-1-51] 5Department of Neurology, Zhujiang Hospital, Southern Medical University, China.
                [6-ad-9-1-51] 6School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
                [7-ad-9-1-51] 7Department of Geriatric Medicine, Hunan Provincial People’s Hospital, Changsha, Hunan, China.
                [8-ad-9-1-51] 8Department of Microbiology & Immunology, School of Medicine, New York Medical College, NY 10595, USA
                Author notes
                [* ]Correspondence should be addressed to: Dr. Qing Wang, The Third Affiliated Hospital of Sun Yat-Sen University, Guangdong, China, Email: denniswq@ 123456yahoo.com. Dr. Penghua Wang, School of Medicine, New York Medical College, NY 10595, USA. Email: penghua_wang@ 123456nymc.edu. Or Dr. Lihui Liang, Hunan Provincial People’s Hospital, Hunan, China. Email: 416284649@ 123456qq.com
                [†]

                These authors contributed equally

                Article
                ad-9-1-51
                10.14336/AD.2017.0416
                5772858
                29392081
                bfaf8771-f15b-4e0a-a6c7-41248dae3530
                Copyright: © 2017 Zhou et al.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 8 February 2017
                : 13 April 2017
                : 16 April 2017
                Categories
                Orginal Article

                tff3,che activity,hcy,parkinson disease dementia,vascular parkinsonism dementia,pathogenesis

                Comments

                Comment on this article